Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
JAGSONPAL PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

JAGSONPAL PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 83.21-18.9040.1821.22112.25

What is the latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS is 83.21 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202583.21
Mar2024-18.90
Mar202340.18
Mar202221.22
Mar2021112.25

How is Core EBITDA Growth of JAGSONPAL PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 83.21
Positive
Mar2024 -18.9
Negative
Mar2023 40.18
89.35
Mar2022 21.22
-81.10
Mar2021 112.25 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,279.7 Cr 3.6% 12% -11.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,326.0 Cr -2.2% -1.8% -2.4% Stock Analytics
DIVIS LABORATORIES ₹155,282.0 Cr -1.6% -7.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,043.0 Cr -4.1% -6.7% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,854.2 Cr -4.7% -7.3% 6.4% Stock Analytics
CIPLA ₹97,115.7 Cr -1.7% -8.4% -16.7% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

3.6%

12%

-11.7%

SENSEX

1.4%

-7%

-3.9%


You may also like the below Video Courses